These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16528264)

  • 1. Nephrotoxicity of low-osmolar and iso-osmolar contrast media.
    Heinrich M; Uder M
    Kidney Int; 2006 Mar; 69(6):1095. PubMed ID: 16528264
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of thrombogenicity among nonionic radiocontrast agents.
    Georgakis A; Ener RA; Jin J; Kunapuli S; Fiss D; Leech SH; Wolf NM; Van Decker WA
    J Invasive Cardiol; 2008 Jul; 20(7):349-53. PubMed ID: 18599893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of renal and hepatic impairment by ionic and nonionic contrast media.
    Langer M; Langer R; Felix R; Speck U; Behrends B; Mützel W
    Invest Radiol; 1990 Sep; 25 Suppl 1():S125-6. PubMed ID: 2283230
    [No Abstract]   [Full Text] [Related]  

  • 4. Iodinated contrast media: effect of osmolarity and injection temperature on erythrocyte morphology in vitro.
    Kerl JM; Nguyen SA; Lazarchick J; Powell JW; Oswald MW; Alvi F; Costello P; Vogl TJ; Schoepf UJ
    Acta Radiol; 2008 Apr; 49(3):337-43. PubMed ID: 18365824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incompatibility of contrast medium and trisodium citrate.
    Delcour C; Bruninx G
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):237-8. PubMed ID: 22696011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity.
    Jost G; Lenhard DC; Sieber MA; Lengsfeld P; Hütter J; Pietsch H
    Invest Radiol; 2011 Dec; 46(12):796-800. PubMed ID: 21808199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of iotrolan, iopamidol, and iopromide in rats with and without experimental nephropathy.
    Uchimoto R; Miyazawa T; Fritz-Zieroth B
    Invest Radiol; 1994 Jun; 29 Suppl 2():S111-2. PubMed ID: 7928202
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospects of the use of non-ionic X-ray contrast substances during endoscopic retrograde cholangiopancreatography].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2003; (6):62-3. PubMed ID: 14674360
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of low-osmolar contrast medium iopromide and iso-osmolar iodixanol on DNA fragmentation in renal tubular cell culture.
    Ludwig U; Connemann J; Keller F
    Clin Exp Nephrol; 2013 Dec; 17(6):779-82. PubMed ID: 23345070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of contrast media on synaptosomal phosphatidylinositols.
    Ekholm SE; Morris TW; Marinetti GV
    Invest Radiol; 1990 Sep; 25 Suppl 1():S84-5. PubMed ID: 2283268
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrast nephrotoxicity and iso-osmolar contrast agents: implications of NEPHRIC.
    Nicholson T; Downes M
    Clin Radiol; 2003 Sep; 58(9):659-60. PubMed ID: 12943635
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
    Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
    Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
    Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
    Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol.
    Heinrich M; Schneider G; Grgic A; Humke U; Kramann B; Uder M
    Invest Radiol; 2004 Jul; 39(7):406-12. PubMed ID: 15194911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media?
    Gomi T; Nagamoto M; Hasegawa M; Katoh A; Sugiyama M; Murata N; Kunihiro T; Kohda E
    Eur Radiol; 2010 Jul; 20(7):1631-5. PubMed ID: 20033176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.